| Patents for C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702) |
|---|
| 07/25/2007 | CN101003504A Processes and intermediates for the preparations of prostaglandins |
| 07/25/2007 | CN101003503A Process for the preparation of prostaglandins and analogues thereof |
| 07/11/2007 | EP1805139A2 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 06/26/2007 | US7235586 prostaglandin derivatives such as (Z)-7-((1R,2S,3R)-2-Butylcarbamoyloxymethyl-3-hydroxy-5-oxo-cyclopentyl)-hept-5-enoic acid methyl ester, administering to mammals for treatment of ocular hypertension; hypotensive agents |
| 06/07/2007 | WO2006101867A3 Treatment of inflammatory bowel disease |
| 06/07/2007 | US20070129327 2-[(2-{(1R,2R)-2-[(1E)-4-hydroxy-4-methyl-1-nonenyl]-5-oxocyclopentyl}ethyl)sulfanyl]-1,3-thiazole-4-carboxylic acid; isomers; increase blood flow for improving symptoms such as lumbago, lower limb pain, lower limb numbness, intermittent claudication, bladder and rectal disorder or sexual dysfunction |
| 05/29/2007 | CA2401718C Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 05/24/2007 | WO2007057232A1 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments |
| 05/24/2007 | CA2629031A1 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments |
| 05/18/2007 | WO2007056087A1 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 05/18/2007 | CA2628413A1 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 05/17/2007 | US20070112067 for treating or preventing sexual dysfunctions in males and females, for enhancing sexual responses in males and females, and for treating or preventing cerebrovascular disorders, cardiovascular disorders, benign prostatic hyperplasia (BPH), glaucoma, peptic ulcers or for inducing abortions |
| 05/17/2007 | US20070112058 Novel prostamides for the treatment of glaucoma and related diseases |
| 04/26/2007 | US20070092466 in combination with carrier, and optionally activity enhancer; arresting or reversing hair loss, or both, and promoting hair growth; also a mascara; thickening and darkening hair |
| 04/24/2007 | CA2303763C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 04/18/2007 | EP1385526B1 3, 7 thia prostanoic acid derivatives as agents for lowering intraocular pressure |
| 03/22/2007 | WO2007000641A3 Prostaglandin derivatives |
| 03/06/2007 | US7186744 prostaglandin derivatives such as Acetic acid 2-acetoxy-5-(2-{(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((E) (S)-3-hydroxy-oct-1-enyl)-cyclopenyl]-hept-5-enoylamino}-ethyl)-phenyl ester, used for therapy of vision defects |
| 02/28/2007 | CN1301986C Process for preparation of prostaglandins and analogues thereof |
| 02/21/2007 | CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders |
| 02/13/2007 | US7176238 For treating or preventing sexual dysfunctions in males and females, for enhancing sexual responses in males and females, and for treating or preventing cerebrovascular disorders, cardiovascular disorders, benign prostatic hyperplasia, glaucoma, peptic ulcers or for inducing abortions |
| 02/08/2007 | WO2006101244A3 Method and composition for treating mucosal disorders |
| 01/31/2007 | CN1906159A Prostaglandin nitrooxyderivatives |
| 01/16/2007 | US7163959 Prostagladin derivatives for the treatment of glaucoma or ocular hypertension |
| 01/10/2007 | CN1894209A Prostaglandin synthesis |
| 01/10/2007 | CN1893977A Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 01/09/2007 | US7161042 Protected diols for prostaglandin synthesis |
| 01/04/2007 | WO2007000642A1 Fluoroprostaglandins nitroderivatives |
| 01/04/2007 | WO2007000641A2 Prostaglandin derivatives |
| 01/04/2007 | CA2613748A1 Prostaglandin derivatives |
| 01/04/2007 | CA2613010A1 Fluoroprostaglandins nitroderivatives |
| 01/02/2007 | US7157590 Chemical intermediate for vision defect drug |
| 12/28/2006 | WO2006137472A1 Prostaglandin derivative |
| 12/28/2006 | WO2006112742A3 PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES |
| 11/30/2006 | US20060270740 Prostaglandin derivatives |
| 11/28/2006 | US7141706 Protected and unprotected triols for prostaglandin synthesis |
| 11/22/2006 | CN1867310A Composition and method for promoting hair growth |
| 11/15/2006 | EP1721894A1 Process for the synthesis of prostaglandin derivatives |
| 11/08/2006 | CN1283624C Prostaglandin derivatives |
| 11/02/2006 | EP1716113A1 Ep2- receptor agonists |
| 10/26/2006 | WO2006112742A2 PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES |
| 10/04/2006 | EP1707208A1 Blood flow promoters for cauda equina tissues |
| 10/03/2006 | US7115659 Method of treating a condition by administering a prostaglandin derivative |
| 09/28/2006 | WO2006101867A2 Treatment of inflammatory bowel disease |
| 09/28/2006 | WO2006101244A2 Method and composition for treating mucosal disorders |
| 09/28/2006 | WO2006047476A3 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 09/27/2006 | EP1704141A1 Prostaglandin nitrooxyderivatives |
| 09/19/2006 | US7109371 Prostaglandin synthesis |
| 09/06/2006 | CN1273140C Cathartic composition |
| 08/30/2006 | EP1694641A2 Prostaglandin synthesis |
| 08/17/2006 | US20060182689 Process for separating out at least one organic compound |
| 08/03/2006 | US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 07/26/2006 | EP1682498A1 Novel prostamides for the treatment of glaucoma and related diseases |
| 07/19/2006 | CN1264820C Ocular hypotensive lipids |
| 07/19/2006 | CN1264819C Process for stereo selective synthesis of prostacyclin derivatives |
| 07/12/2006 | CN1263726C Process and intermediates to prepare latanoprost |
| 07/11/2006 | US7074942 2-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| 07/05/2006 | CN1262309C Remedies for diseases in association with decreasing in bone mass |
| 06/28/2006 | EP1673058A1 Composition and method for promoting hair growth |
| 06/20/2006 | US7064148 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis; lubiprostone |
| 06/15/2006 | WO2006063179A1 12-aryl prostaglandin analogs |
| 06/15/2006 | CA2589864A1 12-aryl prostaglandin analogs |
| 06/13/2006 | CA2324590C C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists |
| 06/13/2006 | CA2180008C Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 06/08/2006 | US20060122411 Chloride channel opener |
| 06/07/2006 | EP1663961A1 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy compounds as therapeutic agents |
| 06/01/2006 | WO2006058063A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 06/01/2006 | CA2588599A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 05/26/2006 | WO2006055481A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 05/26/2006 | CA2588056A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 05/24/2006 | CN1777580A Prostaglandin derivatives |
| 05/18/2006 | US20060106236 Protected and unprotected triols for prostaglandin synthesis |
| 05/18/2006 | US20060106235 2-allyl-4-hydroxycyclopentanone 3-substituted with 3-hydroxy-5-phenylpentyl- or 3-hydroxy-4-(m-trifluoromethylphenyl)butyl- derivatives in which the hydroxy groups are protected , especially by tetrahydropyranyl groups, and the pentyl or butyl chain may be 2-unsaturated |
| 05/17/2006 | CN1774417A A new process for the preparation of 17-phenyl-18, 19, 20-trinor-PGF2A and its derivatives |
| 05/04/2006 | WO2006047476A2 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 05/04/2006 | US20060094788 Prostaglandin derivatives |
| 05/04/2006 | CA2585367A1 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 04/20/2006 | WO2006041875A1 Novel prostamides for the treatment of glaucoma and related diseases |
| 04/12/2006 | CN1758915A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/12/2006 | CN1757636A Method for preparing prostaglandin F derivative, and novel intermediate thereof |
| 02/15/2006 | CN1241570C Bile secretion promoting composition |
| 02/09/2006 | WO2005068421A8 Prostaglandin nitrooxyderivatives |
| 01/25/2006 | EP1082961B1 Sleep inducing agent comprising prostaglandin derivatives |
| 01/24/2006 | US6989458 Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
| 12/28/2005 | EP1608309A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 12/20/2005 | CA2181569C Ep2-receptor agonists as agents for lowering intraocular pressure |
| 12/14/2005 | EP1267803B1 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 12/08/2005 | US20050272877 Process for the preparation of prostaglandins and analogues thereof |
| 12/08/2005 | US20050272743 Nitroxy derivatives, e.g., 4-(nitrooxy)butyl [1R-[1 alpha (Z),2 alpha (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenoate; used for the treatment of glaucoma and ocular hypertension |
| 11/30/2005 | CN1229342C Omega-naphthenic base prostaglandin E2 derivatives |
| 11/24/2005 | US20050261375 Method for providing a cathartic effect |
| 11/24/2005 | US20050261374 Process for the preparation of prostaglandins and analogues thereof |
| 11/23/2005 | EP1598335A1 Prostaglandin derivatives |
| 11/23/2005 | EP1021402B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 11/10/2005 | WO2004071428A3 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 11/02/2005 | EP0930296B2 Fluorinated prostaglandin derivatives and medicines |
| 10/18/2005 | US6956056 Method for providing a cathartic effect |
| 10/13/2005 | WO2005058812A3 Prostaglandin synthesis |
| 10/12/2005 | CN1222509C Prostaglandin derives. |
| 09/22/2005 | US20050209336 EP2 receptor agonists |